Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)
Overview
Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)
Source
Originally published at www.cnbc.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.